182 related articles for article (PubMed ID: 35092833)
1. Curcumin mitigates Cryptosporidium parvum infection through modulation of gut microbiota and innate immune-related genes in immunosuppressed neonatal mice.
Rahman SU; Zhou K; Zhou S; Sun T; Mi R; Huang Y; Han X; Gong H; Chen Z
Microb Pathog; 2022 Mar; 164():105424. PubMed ID: 35092833
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
[TBL] [Abstract][Full Text] [Related]
3. Chitosan Protects Immunosuppressed Mice Against
Rahman SU; Gong H; Mi R; Huang Y; Han X; Chen Z
Front Immunol; 2021; 12():784683. PubMed ID: 35095858
[No Abstract] [Full Text] [Related]
4. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
[TBL] [Abstract][Full Text] [Related]
5. Cryptosporidium parvum-Infected Neonatal Mice Show Gut Microbiota Remodelling Using High-Throughput Sequencing Analysis: Preliminary Results.
Mammeri M; Chevillot A; Thomas M; Julien C; Auclair E; Pollet T; Polack B; Vallée I; Adjou KT
Acta Parasitol; 2019 Jun; 64(2):268-275. PubMed ID: 30915719
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells.
VanDussen KL; Funkhouser-Jones LJ; Akey ME; Schaefer DA; Ackman K; Riggs MW; Stappenbeck TS; Sibley LD
mBio; 2020 Dec; 11(6):. PubMed ID: 33323514
[TBL] [Abstract][Full Text] [Related]
7. Host innate immune responses and microbiome profile of neonatal calves challenged with
Gamsjäger L; Cirone KM; Schluessel S; Campsall M; Herik A; Lahiri P; Young D; Dufour A; Sapountzis P; Otani S; Gomez DE; Windeyer MC; Cobo ER
Front Cell Infect Microbiol; 2023; 13():1165312. PubMed ID: 37207189
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
10. Probiotic Product Enhances Susceptibility of Mice to Cryptosporidiosis.
Oliveira BCM; Widmer G
Appl Environ Microbiol; 2018 Nov; 84(21):. PubMed ID: 30171003
[TBL] [Abstract][Full Text] [Related]
11. Perturbation of the intestinal microbiota of mice infected with Cryptosporidium parvum.
Ras R; Huynh K; Desoky E; Badawy A; Widmer G
Int J Parasitol; 2015 Jul; 45(8):567-73. PubMed ID: 25913477
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the prophylactic and therapeutic effects of paromomycin, recombinant IL-12 alone or in combination against Cryptosporidium parvum infection in immunosuppressed mice.
Gamra MM; el-Hosseiny LM
J Egypt Soc Parasitol; 2003 Apr; 33(1):109-22. PubMed ID: 12739805
[TBL] [Abstract][Full Text] [Related]
14. Specific increase of Fusobacterium in the faecal microbiota of neonatal calves infected with Cryptosporidium parvum.
Ichikawa-Seki M; Motooka D; Kinami A; Murakoshi F; Takahashi Y; Aita J; Hayashi K; Tashibu A; Nakamura S; Iida T; Horii T; Nishikawa Y
Sci Rep; 2019 Aug; 9(1):12517. PubMed ID: 31467354
[TBL] [Abstract][Full Text] [Related]
15. Patent gut infections in immunosuppressed adult C57BL/6N mice following intraperitoneal injection of Cryptosporidium parvum oocysts.
Yang S; Healey MC
J Parasitol; 1994 Apr; 80(2):338-42. PubMed ID: 8158484
[TBL] [Abstract][Full Text] [Related]
16. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
[TBL] [Abstract][Full Text] [Related]
17. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.
Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R
Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628
[TBL] [Abstract][Full Text] [Related]
18. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
Rasmussen KR; Healey MC; Cheng L; Yang S
J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
20. Microbiome-Metabolomics Analysis of the Impacts of
Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
